• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Retinal vessels modifications in acute and post-COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Sep 29;11(1):19373.
doi: 10.1038/s41598-021-98873-1.
Retinal vessels modifications in acute and post-COVID-19


Alessandro Invernizzi[SUP] 1 2 3 [/SUP], Marco Schiuma[SUP] 4 5 [/SUP], Salvatore Parrulli[SUP] 6 [/SUP], Alessandro Torre[SUP] 5 [/SUP], Federico Zicarelli[SUP] 6 [/SUP], Valeria Colombo[SUP] 5 [/SUP], Sara Marini[SUP] 6 [/SUP], Elena Villella[SUP] 6 [/SUP], Alice Bertoni[SUP] 6 [/SUP], Spinello Antinori[SUP] 4 5 [/SUP], Giuliano Rizzardini[SUP] 5 [/SUP], Massimo Galli[SUP] 4 5 [/SUP], Luca Meroni[SUP] 5 [/SUP], Andrea Giacomelli[SUP] 5 [/SUP], Giovanni Staurenghi[SUP] 6 4 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study investigated retinal vessels during the acute phase of COVID-19 and after patients recovery. Fifty-nine eyes from 32 COVID-19 patients and 80 eyes from 53 unexposed subjects were included. Mean arteries diameter (MAD) and mean veins diameter (MVD) were assessed through semi-automatic analysis on fundus color photos at baseline and 6 months later in patients and subjects unexposed to the virus. At baseline MAD and MVD were significantly higher in COVID-19 patients compared to unexposed subjects (p < 0.0001). Both MAD and MVD significantly decreased in COVID-19 patients at follow-up (from 97.5 ± 10.9 to 92.2 ± 11.4 µm, p < 0.0001 and from 133.1 ± 19.3 to 124.6 ± 16.1 µm, p < 0.0001, respectively). Despite this reduction vessels diameter remained significantly higher in severe COVID-19 patients compared to unexposed subjects. Transient retinal vessels dilation could serve a biomarker for systemic inflammation while long-lasting alterations seen in severe COVID-19 likely reflect irreversible structural damage to the vessels walls and should be further investigated for their possible effects on tissues perfusion and function.
 
Back
Top Bottom